logo
3 Places Where Your ‘Fernweh' Is Likely To Go Off The Charts, By A Psychologist

3 Places Where Your ‘Fernweh' Is Likely To Go Off The Charts, By A Psychologist

Forbes27-05-2025
'Fernweh' is a German word that has no true English equivalent, but the feeling is both universal ... More and bittersweet. Here's where you can go to feel more of it.
There's a nuance between the German words fernweh and wanderlust. Wanderlust, originally German for 'a desire to hike or roam,' has taken on a more playful tone in English. It's now the kind of word you'd throw on a travel blog or an Instagram story. Fernweh, by contrast, is deeper.
It's the kind of thing you reserve for your Sunday night conversations with yourself, when the world feels slightly off-kilter and your chest tightens with the feeling that you belong somewhere else, even if you don't know where.
It's hard to explain fernweh without mentioning heimweh, the German word for homesickness. The two are rough opposites. So if heimweh is missing a place you know all too well, fernweh is an aching for a place you've never been.
But here's the beauty of the word: It's not entirely sad. Fernweh carries a kind of bittersweet connotation, much like longing with a hint of hope. And if you want to lean into that complex emotion, here are three places you can go to feel it more deeply.
There's something about sitting in a dark movie theater, eyes wide, sound all around you, that makes the world outside feel inconsequential. And for many, that's exactly when fernweh creeps in.
In 2023, over 819 million movie tickets were sold in the U.S. But by 2025, that number dropped to around 697 million. But even as the numbers decline, the effects of watching a movie in a theater remain potent.
A 2023 study published in Marketing Letters shows that people actually prefer the big screen experience over the home video experience. The difference is visible in the ratings they leave.
The big screen gives your fernweh room to breathe. Because when you're sitting at the movies and the Glacier Express chugs through the Swiss Alps, or the camera pulls back on an old town in Morocco, you're already there. That's what good cinema does, it immerses you in another life for a few minutes.
If you've ever thought of an airport as a portal to strange human behavior, you're not alone.
We've all seen it: people drinking wine at 7 a.m. or doing impossible yoga poses near Gate 14. And sometimes, it gets darker. Arguments, panic attacks or even the occasional in-flight outbursts make headlines.
Researchers point to sensory overload, lack of control, time distortion and even the loosening of social norms as triggers. In short: airports, by their very nature, make people behave differently.
And they also make people yearn. You're surrounded by lives in transition from one 'life' to another. Even if you're not flying — and you're just seeing someone off — you can still feel it in your bones. That buzzing emotional frequency is fertile ground for fernweh to grow.
Sometimes, just being near the departure board is enough. Maybe you glance at flights to Reykjavik, Seoul or Nairobi and feel something. Maybe a small part of you wonders what your life would look like if you belonged there. Or at least it wants to know what it's like to be there, even briefly.
Watching your own city's skyline is an underrated way to wind down. There's something quietly reassuring about realizing the world doesn't depend on you, that what you think of as 'your life' will keep moving, with or without your participation.
There's a reason we're drawn to high places — hotel balconies, hilltops or the 100th floor of a skyscraper. As psychologist Sally Augustin, PhD, puts it, being up high gives us prospect and refuge: a broad view of the world from a secure, safe place. Seen from above, the world looks both beautiful and available. And in that moment, fernweh often stirs.
Because sometimes, all it takes is a bird's-eye view to wonder who else you could be, and where you'd have to go to meet that version of yourself.
Do you feel deeply connected to natural spaces, even if they're far away? Take this science-backed test to find out: Connectedness To Nature Scale
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

H.C. Wainwright Lifts PT on Atai Life Sciences (ATAI) to $15 From $10
H.C. Wainwright Lifts PT on Atai Life Sciences (ATAI) to $15 From $10

Yahoo

timean hour ago

  • Yahoo

H.C. Wainwright Lifts PT on Atai Life Sciences (ATAI) to $15 From $10

Atai Life Sciences (NASDAQ:ATAI) is one of the best biotech penny stocks to buy right now. On July 30, H.C. Wainwright analyst Patrick Trucchio raised the firm's price target on Atai Life Sciences (NASDAQ:ATAI) to $15 from $10 while keeping a Buy rating on the shares. A close-up of a medical professional providing advice to a patient struggling with opioid use disorder. The firm told investors that it is bullish on Atai Life Sciences (NASDAQ:ATAI) despite the Phase 2b trial, which evaluated indiabine in patients with cognitive impairment associated with schizophrenia, missing the primary endpoint. The analyst added in a research note that management reiterated Atai Life Sciences' (NASDAQ:ATAI) focus on its wholly-owned psychedelics pipeline in a follow-up call. This includes BPL-003, which has continued to surpass expectations. The firm thus cited Atai Life Sciences' (NASDAQ:ATAI) focus on its 'most promising near-term asset' for the target upgrade. Headquartered in Germany, Atai Life Sciences (NASDAQ:ATAI) is a clinical-stage biopharmaceutical company focused on treating mental health disorders. While we acknowledge the potential of ATAI as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Jim Cramer on Royal Caribbean: 'Expectations Simply Got Too High'
Jim Cramer on Royal Caribbean: 'Expectations Simply Got Too High'

Yahoo

time2 hours ago

  • Yahoo

Jim Cramer on Royal Caribbean: 'Expectations Simply Got Too High'

Royal Caribbean Cruises Ltd. (NYSE:RCL) is one of the stocks Jim Cramer recently talked about. Cramer discussed the company's earnings and the market reaction to it during the episode. He said: 'Today's earnings made me feel like we'd forgotten the impact of all the tariff turmoil on the consumer. Some of the decline, I think, was an overreaction. Royal Caribbean went down on its outlook. But I gotta tell you, I checked that one out. I think the expectations simply got too high. People got used to this cruise line just crushing the high end of the estimates. Didn't happen.' Nonwarit/ Royal Caribbean (NYSE:RCL) is a cruise operator that provides diverse itineraries through multiple brands, including Royal Caribbean International, Celebrity Cruises, and Silversea Cruises. In a March episode, Cramer mentioned the company and said: 'What else in travel's worth taking a look at?… It's tough for me to square the heinous action with what we just heard from Jason Liberty, the CEO of Royal Caribbean. When he came on the show last week, first, Liberty confirmed that its… consumers perceive Royal Caribbean cruises as a better value than a land-based vacation, reinforcing my view the cruise lines can still do fine even in a softer economy. Second, he cited its own bookings and on-ship spending data from recent voyages saying matter-of-factly, 'that cash register continues to ring and be consistent.' Since the above comment was made, Royal Caribbean (NYSE:RCL) stock is up over 61%. While we acknowledge the potential of RCL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio

Results: Siemens Healthineers AG Beat Earnings Expectations And Analysts Now Have New Forecasts
Results: Siemens Healthineers AG Beat Earnings Expectations And Analysts Now Have New Forecasts

Yahoo

time2 hours ago

  • Yahoo

Results: Siemens Healthineers AG Beat Earnings Expectations And Analysts Now Have New Forecasts

A week ago, Siemens Healthineers AG (ETR:SHL) came out with a strong set of quarterly numbers that could potentially lead to a re-rate of the stock. It was overall a positive result, with revenues beating expectations by 2.0% to hit €5.7b. Siemens Healthineers reported statutory earnings per share (EPS) €0.49, which was a notable 17% above what the analysts had forecast. Earnings are an important time for investors, as they can track a company's performance, look at what the analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. We've gathered the most recent statutory forecasts to see whether the analysts have changed their earnings models, following these results. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. After the latest results, the 18 analysts covering Siemens Healthineers are now predicting revenues of €24.6b in 2026. If met, this would reflect a modest 5.4% improvement in revenue compared to the last 12 months. Per-share earnings are expected to climb 17% to €2.29. In the lead-up to this report, the analysts had been modelling revenues of €24.8b and earnings per share (EPS) of €2.34 in 2026. So it looks like there's been a small decline in overall sentiment after the recent results - there's been no major change to revenue estimates, but the analysts did make a small dip in their earnings per share forecasts. See our latest analysis for Siemens Healthineers The consensus price target held steady at €59.86, with the analysts seemingly voting that their lower forecast earnings are not expected to lead to a lower stock price in the foreseeable future. That's not the only conclusion we can draw from this data however, as some investors also like to consider the spread in estimates when evaluating analyst price targets. There are some variant perceptions on Siemens Healthineers, with the most bullish analyst valuing it at €65.00 and the most bearish at €50.00 per share. This is a very narrow spread of estimates, implying either that Siemens Healthineers is an easy company to value, or - more likely - the analysts are relying heavily on some key assumptions. These estimates are interesting, but it can be useful to paint some more broad strokes when seeing how forecasts compare, both to the Siemens Healthineers' past performance and to peers in the same industry. It's pretty clear that there is an expectation that Siemens Healthineers' revenue growth will slow down substantially, with revenues to the end of 2026 expected to display 4.3% growth on an annualised basis. This is compared to a historical growth rate of 9.0% over the past five years. Compare this against other companies (with analyst forecasts) in the industry, which are in aggregate expected to see revenue growth of 5.6% annually. So it's pretty clear that, while revenue growth is expected to slow down, the wider industry is also expected to grow faster than Siemens Healthineers. The Bottom Line The biggest concern is that the analysts reduced their earnings per share estimates, suggesting business headwinds could lay ahead for Siemens Healthineers. On the plus side, there were no major changes to revenue estimates; although forecasts imply they will perform worse than the wider industry. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates. Keeping that in mind, we still think that the longer term trajectory of the business is much more important for investors to consider. We have forecasts for Siemens Healthineers going out to 2027, and you can see them free on our platform here. And what about risks? Every company has them, and we've spotted 1 warning sign for Siemens Healthineers you should know about. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store